Stable Istotope Labelled Romilkimab Biosimilar – Anti-IL13/IL4 mAb – Research Grade

Reference: PX-TA1027-SIL-1MG
Product nameStable Istotope Labelled Romilkimab Biosimilar - Anti-IL13/IL4 mAb - Research Grade
SourceIMGT/mAb-DB 794
SpeciesHuman
Expression systemMammalian cells
Molecular weightLC: 36kDa
HC: 63kDa
Purity>95%
BufferPBS pH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage condition4°C for short term; -20°C for long term
BrandProteoGenix
Aliases /SynonymsRomilkimab
ReferencePX-TA1027-SIL
NoteFor research use only. Not suitable for clinical or therapeutic use.
Isotype[VH-VH' Gamma1 + VL-VL' kappa (bispecific)
ClonalityMonoclonal Antibody
SourceIMGT/mAb-DB 794
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

General information about Romilkimab

Romilkimab is an engineered, humanised, bispecific immunoglobulin-G4 antibody that binds and neutralizes IL-4/IL-13 making it ideal for exploration in fibrosis, This product is for research use only.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Istotope Labelled Romilkimab Biosimilar – Anti-IL13/IL4 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.